153 related articles for article (PubMed ID: 1666627)
1. hu-PBL-SCID mice: a model for human immune function, AIDS, and lymphomagenesis.
Torbett BE; Picchio G; Mosier DE
Immunol Rev; 1991 Dec; 124():139-64. PubMed ID: 1666627
[No Abstract] [Full Text] [Related]
2. Epstein-Barr virus-induced human B-cell lymphomas in SCID mice reconstituted with human peripheral blood leukocytes.
Mosier DE; Picchio GR; Baird SM; Kobayashi R; Kipps TJ
Cancer Res; 1992 Oct; 52(19 Suppl):5552s-5553s. PubMed ID: 1327510
[TBL] [Abstract][Full Text] [Related]
3. A model of human anti-T-cell monoclonal antibody therapy in SCID mice engrafted with human peripheral blood lymphocytes.
Tsuchida M; Brown SA; Tutt LM; Tan J; Seehafer DL; Harris JP; Xun CQ; Thompson JS
Clin Transplant; 1997 Oct; 11(5 Pt 2):522-8. PubMed ID: 9361954
[TBL] [Abstract][Full Text] [Related]
4. [The immunodeficient mouse (SCID) as an animal model for AIDS].
Pasqualini CD
Medicina (B Aires); 1990; 50(3):272-3. PubMed ID: 2130217
[No Abstract] [Full Text] [Related]
5. Recombinant human growth hormone promotes human lymphocyte engraftment in immunodeficient mice and results in an increased incidence of human Epstein Barr virus-induced B-cell lymphoma.
Murphy WJ; Durum SK; Anver M; Frazier M; Longo DL
Brain Behav Immun; 1992 Dec; 6(4):355-64. PubMed ID: 1336993
[TBL] [Abstract][Full Text] [Related]
6. Heterogeneity among Epstein-Barr virus-seropositive donors in the generation of immunoblastic B-cell lymphomas in SCID mice receiving human peripheral blood leukocyte grafts.
Picchio GR; Kobayashi R; Kirven M; Baird SM; Kipps TJ; Mosier DE
Cancer Res; 1992 May; 52(9):2468-77. PubMed ID: 1314693
[TBL] [Abstract][Full Text] [Related]
7. Physiologic human T-cell responses to OKT3 in the human peripheral blood lymphocyte-severe combined immunodeficiency mouse model.
Dessureault S; Shpitz B; Alloo J; Rotstein O; Sandhu J; Hozumi N; Fernandes B; Gallinger S
Transplantation; 1997 Sep; 64(6):811-6. PubMed ID: 9326403
[TBL] [Abstract][Full Text] [Related]
8. Potent immune response against HIV-1 and protection from virus challenge in hu-PBL-SCID mice immunized with inactivated virus-pulsed dendritic cells generated in the presence of IFN-alpha.
Lapenta C; Santini SM; Logozzi M; Spada M; Andreotti M; Di Pucchio T; Parlato S; Belardelli F
J Exp Med; 2003 Jul; 198(2):361-7. PubMed ID: 12874266
[TBL] [Abstract][Full Text] [Related]
9. EBV-induced human B cell lymphomas in hu-PBL-SCID mice.
Mosier DE; Picchio GR; Kirven MB; Garnier JL; Torbett BE; Baird SM; Kobayashi R; Kipps TJ
AIDS Res Hum Retroviruses; 1992 May; 8(5):735-40. PubMed ID: 1325170
[TBL] [Abstract][Full Text] [Related]
10. Lymphoproliferative disease in SCID mice reconstituted with human Sjögren's syndrome lymphocytes.
Fox RI; Pisa P; Pisa EK; Kang HI
J Clin Lab Anal; 1993; 7(1):46-56. PubMed ID: 8381174
[TBL] [Abstract][Full Text] [Related]
11. Xenogeneic PBL-scid mice: their potential and current limitations.
Greenwood JD
Lab Anim Sci; 1993 Apr; 43(2):151-5. PubMed ID: 8320963
[TBL] [Abstract][Full Text] [Related]
12. Resistance to human immunodeficiency virus 1 infection of SCID mice reconstituted with peripheral blood leukocytes from donors vaccinated with vaccinia gp160 and recombinant gp160.
Mosier DE; Gulizia RJ; MacIsaac PD; Corey L; Greenberg PD
Proc Natl Acad Sci U S A; 1993 Mar; 90(6):2443-7. PubMed ID: 8460155
[TBL] [Abstract][Full Text] [Related]
13. Human B-cell lymphoma in severe combined immunodeficient mice after active infection with Epstein-Barr virus.
Boyle TJ; Tamburini M; Berend KR; Kizilbash AM; Borowitz MJ; Lyerly HK
Surgery; 1992 Aug; 112(2):378-86. PubMed ID: 1322566
[TBL] [Abstract][Full Text] [Related]
14. Engraftment of human peripheral blood leukocytes into severe combined immunodeficient mice results in the long term and dynamic production of human xenoreactive antibodies.
Williams SS; Umemoto T; Kida H; Repasky EA; Bankert RB
J Immunol; 1992 Oct; 149(8):2830-6. PubMed ID: 1401915
[TBL] [Abstract][Full Text] [Related]
15. hu-PBL-SCID mice: an in vivo model of Epstein-Barr virus-dependent lymphoproliferative disease.
Fuzzati-Armentero MT; Duchosal MA
Histol Histopathol; 1998 Jan; 13(1):155-68. PubMed ID: 9476646
[TBL] [Abstract][Full Text] [Related]
16. The hu-PBL-SCID mouse model. Long-term human serologic evolution associated with the xenogeneic transfer of human peripheral blood leukocytes into SCID mice.
Duchosal MA; Eming SA; McConahey PJ; Dixon FJ
Cell Immunol; 1992 Feb; 139(2):468-77. PubMed ID: 1733515
[TBL] [Abstract][Full Text] [Related]
17. The fate of human peripheral blood lymphocytes after transplantation into SCID mice.
Martino G; Anastasi J; Feng J; Mc Shan C; DeGroot L; Quintans J; Grimaldi LM
Eur J Immunol; 1993 May; 23(5):1023-8. PubMed ID: 8477797
[TBL] [Abstract][Full Text] [Related]
18. Analysis of the adoptive transfer of delayed hypersensitivity and T cell repertoire in severe combined immunodeficiency mice reconstituted with human lymphocytes.
Mancia L; Mariani F; Mattei M; Montesano C; Placido R; Colizzi V; Salerno A; Bellavia A
Folia Biol (Praha); 1994; 40(6):411-30. PubMed ID: 7589700
[TBL] [Abstract][Full Text] [Related]
19. Human peripheral blood leukocyte-reconstituted severe combined immunodeficient mouse: analysis of the human immune response against porcine islet transplantation.
Shiroki R; Naziruddin B; Shishido S; Duffy BF; Howard T; Mohanakumar T
Transplantation; 1997 Mar; 63(6):818-23. PubMed ID: 9089220
[TBL] [Abstract][Full Text] [Related]
20. Human T cells in hu-PBL-SCID mice proliferate in response to Daudi lymphoma and confer anti-tumour immunity.
Malkovska V; Cigel F; Storer BE
Clin Exp Immunol; 1994 Apr; 96(1):158-65. PubMed ID: 8149661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]